Trimi is an online weight-management platform that states it was founded in May 2024 and is headquartered in New York City. According to the company, treatment is available in all 50 states through licensed clinicians affiliated with Arora Health.
The platform connects eligible adults with clinicians who may prescribe compounded semaglutide or compounded tirzepatide when medically appropriate. Trimi states that its annual-plan pricing includes medication, clinician visits, ongoing check-ins, 24/7 provider messaging, and free overnight shipping. The company also advertises the same membership price across prescribed dose levels.
Trimi offers two main treatment programs: compounded semaglutide and compounded tirzepatide. Both are administered as once-weekly injections and require a clinician’s review and prescription. Trimi lists compounded semaglutide at $99 per month and compounded tirzepatide at $125 per month with annual plans.
Customers begin by completing an online assessment covering their medical history, daily habits, current health information, and weight-management goals. A licensed clinician reviews the information and may recommend a treatment plan if medication is considered appropriate. Trimi states that prescribed medication is delivered in discreet packaging with free overnight shipping.
Treatment and prescription approval are not guaranteed. Eligibility depends on factors such as medical history, contraindications, current medications, and the clinician’s independent judgment. Trimi states that its compounded medications are prepared for individual prescriptions by state-licensed 503A compounding pharmacies. Compounded medications are not FDA-approved as finished drug products.
Plan | Current listed price | Plan length | What’s included |
Compounded semaglutide | $99/month | Annual plan | Medication, clinician visits, ongoing check-ins, provider messaging, and free overnight shipping |
Compounded tirzepatide | $125/month | Annual plan | Medication, clinician visits, ongoing check-ins, provider messaging, and free overnight shipping |
Disclaimer: Prices reflect Trimi’s currently advertised annual-plan rates and may be subject to eligibility, clinician approval, billing terms, and change. Compounded medications are not FDA-approved.
Trimi lists compounded semaglutide at $99 per month and compounded tirzepatide at $125 per month with annual plans. That works out to $1,188 per year for semaglutide and $1,500 per year for tirzepatide. Trimi states that the price stays the same if a patient’s prescribed dose changes.
The plans include medication, clinician consultations and check-ins, provider messaging, injection supplies, and free shipping. Trimi also accepts FSA and HSA funds, although eligibility and reimbursement depend on the customer’s individual plan.
Keep in mind that the advertised $99 and $125 rates are monthly equivalents rather than month-to-month prices. The annual plan is paid upfront or through an available financing option. Before enrolling, customers should check the total cost, billing schedule, shipment frequency, cancellation policy, and refund terms.
Trimi also advertises a six-month money-back promise. Customers who follow their treatment plan for six months without losing weight may request a refund. Terms and eligibility requirements apply, so it is important to read the full refund policy.
Trimi describes a three-step online process. Customers first complete an assessment covering their health, lifestyle, medical history, and weight-management goals. A licensed clinician then reviews the information and decides whether GLP-1 treatment is appropriate. If treatment is approved and prescribed, the medication is prepared by one of Trimi’s compounding-pharmacy partners and shipped to the customer’s address.
Trimi says clinical care is provided through Arora Health, its clinical-infrastructure partner and provider network. Arora Health was founded by Dr. Sean Arora, who also serves as Trimi’s medical director. Trimi advertises treatment access in all 50 states and Washington, D.C. Customers can use its secure portal to manage refills, request dose changes, and message their care team. Dose changes require review and approval from a licensed clinician.
A prescription is not guaranteed. Trimi lists general eligibility criteria that include a BMI of at least 30 or a BMI of at least 27 with a weight-related health condition. A clinician will also review the customer’s medical history, current medications, possible contraindications, and pregnancy or breastfeeding status before deciding whether treatment is appropriate.
Trimi provides some transparency by publicly identifying its clinical and pharmacy partners. The company says medical evaluations are handled through Arora Health and names VialsRx and GreenwichRx as its compounding-pharmacy partners. The Texas State Board of Pharmacy lists VialsRx under pharmacy license No. 35264. Trimi describes its pharmacy partners as operating under Section 503A, which applies to pharmacies that prepare compounded medications for individual prescriptions.
It is important to understand that compounded semaglutide and tirzepatide are not FDA-approved as finished drug products. According to the FDA, compounded medications do not undergo premarket review for safety, effectiveness, or quality. Trimi discloses the compounded status of its medications on its website.
Customer feedback is mixed. When checked on July 18, 2026, Trimi’s Trustpilot profile displayed 61 reviews, with 44% awarding five stars and 48% awarding one star. Trustpilot had made the company’s overall rating unavailable and stated that it had removed a number of fake reviews from the profile.
Positive reviews commonly mentioned convenient ordering, delivery, and responsive service. Critical reviews raised concerns about communication, dosing, treatment results, refunds, and cancellations. Because online reviews reflect individual experiences, customers should consider them alongside clinician guidance, pharmacy licensing information, medication risks, and the company’s written billing and refund terms.
Trimi lists customer support by telephone at (855) 200-2563 and by email at care@trytrimi.com. Its website displays telephone support hours of 9 a.m. to 6 p.m. Eastern Time, although the specific operating days are not stated in the accessible footer.
The company also advertises 24/7 provider messaging through its patient portal. Customers can use the portal to manage refills, ask treatment questions, request dose changes, and communicate with the care team.
Trimi provides an FAQ section, treatment guides, safety information, a blog, dosage resources, cost guides, and an online contact page. The FAQ covers treatment eligibility, medication, pricing, shipments, side effects, privacy, cancellation, and support.
A complete street address was not prominently published in the accessible support information. Trimi identifies its headquarters as New York City, New York. Customers requiring a legal or mailing address should check the company’s terms, privacy policy, prescription documents, or payment receipt.
One of Trimi’s main distinguishing features is its advertised annual-plan pricing. Compounded semaglutide is listed at the equivalent of $99 per month, or $1,188 per year, while compounded tirzepatide is listed at $125 per month, or $1,500 per year. Trimi says these plans include medication, clinician care, ongoing check-ins, provider messaging, and free overnight shipping once the medication is prepared.
The company also states that its pricing remains the same at every prescribed dose. This may make treatment costs more predictable than programs that charge more as the dose increases. However, customers should review the total annual cost, billing arrangement, cancellation policy, and refund terms before enrolling.
Another notable feature is that Trimi publicly identifies its clinical and pharmacy partners. The company names Arora Health as its clinical-infrastructure partner and provider network and identifies VialsRx and GreenwichRx as its compounding-pharmacy partners.
Semaglutide from $99 per month: Trimi lists compounded semaglutide at the equivalent of $99 per month with an annual plan totaling $1,188.
Tirzepatide from $125 per month: Trimi lists compounded tirzepatide at the equivalent of $125 per month with an annual plan totaling $1,500.
Same price at every dose: Trimi states that the plan price does not increase when a clinician adjusts a patient’s prescribed dose.
Free overnight shipping: Trimi advertises free overnight shipping in discreet packaging after the prescription is approved and the medication is prepared.
Clinician care included: Trimi says its plan price includes clinician review, ongoing check-ins, and treatment support.
24/7 portal and provider messaging: Customers can access the secure patient portal at any time to request refills, ask about dose changes, and message their care team. Response times may vary.
Trimi may be a good option for eligible adults seeking a cash-pay, fully online GLP-1 weight-management program with predictable pricing. The company lists compounded semaglutide from $99 per month and compounded tirzepatide from $125 per month on annual plans. According to Trimi, the advertised price includes medication, clinician visits, ongoing check-ins, provider messaging, and free overnight shipping.
Prospective customers should review the program carefully before enrolling. Compounded medications are not FDA-approved as finished drug products, and the lowest published prices require an annual plan. Customers should also review the refund policy, shipping and cancellation terms, clinician communication process, and recent customer feedback before making a decision.
Having explored the features and benefits of this product, you might be curious about how it stacks up against its competitors. We encourage you to visit our comprehensive comparison chart for a broader perspective. This chart offers a detailed juxtaposition of this product with other leading brands, highlighting differences in features, pricing, and customer ratings. It’s an invaluable resource for contrasting your options and making an informed decision that best suits your needs. Don’t miss out – take a moment now to view our comparison chart and see how your chosen product compares in the wider market.
AI was used in the creation of this content, along with human validation and proofreading.
Top10.com's editorial staff is a professional team of editors and writers with dozens of years of experience covering consumer, financial and business products and services.